Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Colorectal Neoplasm Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02339116
What this trial is testing

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 654
Not applicableActive Not RecruitingNCT04161092
What this trial is testing

The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Liver Metastases
Vastra Gotaland Region 45
Testing effectiveness (Phase 2)UnknownNCT05035381
What this trial is testing

PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer

Who this might be right for
MSI-H Advanced Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06885034
What this trial is testing

Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 451
Large-scale testing (Phase 3)Looking for participantsNCT06509126
What this trial is testing

Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IV
National Cancer Institute, Naples 500
Testing effectiveness (Phase 2)UnknownNCT05167448
What this trial is testing

ES104 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Elpiscience (Suzhou) Biopharma, Ltd. 58
Not applicableUnknownNCT01048216
What this trial is testing

Partial Liver Radiotherapy for Unresectable Liver Metastases

Who this might be right for
Metastatic Colorectal Liver Cancer
Royal Marsden NHS Foundation Trust 18
Testing effectiveness (Phase 2)WithdrawnNCT01293942
What this trial is testing

IXO+A in mCRC With Liver-only Metastases

Who this might be right for
Metastatic Colorectal Cancer
Ottawa Hospital Research Institute
Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)UnknownNCT05289076
What this trial is testing

Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model

Who this might be right for
Colorectal Cancer MetastaticTumour MetastasisChemotherapy Effect+1 more
University Hospital, Linkoeping 40
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Looking for participantsNCT06218810
What this trial is testing

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerMicrosatellite Stable Colorectal CarcinomaRAS Mutation+1 more
Fudan University 53
Large-scale testing (Phase 3)UnknownNCT03783559
What this trial is testing

TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Fudan University 168
Testing effectiveness (Phase 2)UnknownNCT01763450
What this trial is testing

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
Liaoning Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446387
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 70
Testing effectiveness (Phase 2)UnknownNCT06003998
What this trial is testing

Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab

Who this might be right for
Colorectal CancerPeritoneal Metastases
Catharina Ziekenhuis Eindhoven 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Early research (Phase 1)Study completedNCT01787500
What this trial is testing

Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Who this might be right for
BRAF NP_004324.2:p.V600XKRAS wt AlleleMetastatic Malignant Solid Neoplasm+4 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)WithdrawnNCT04430985
What this trial is testing

FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Dorte Nielsen
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Next Page